Voyager Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2014 | — | $-20.8M | $7.0M |
| FY2015 | — | $169.1M | $31.3M |
| FY2016 | — | $135.9M | $36.6M |
| FY2017 | — | $134.1M | $31.5M |
| FY2018 | — | $46.4M | $46.9M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2014 | — | $-20.8M | $7.0M |
| FY2015 | — | $169.1M | $31.3M |
| FY2016 | — | $135.9M | $36.6M |
| FY2017 | — | $134.1M | $31.5M |
| FY2018 | — | $46.4M | $46.9M |